Tuberculosis in asymptomatic HIV-infected adults with abnormal chest radiographs screened for tuberculosis prevention

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 1, 2010, Pages 45-51

  Agizew, T B ^a   Arwady, M A ^a   Yoon, J C ^a   Nyirenda, S ^a   Mosimaneotsile, B ^a   Tedla, Z ^a   Motsamai, O ^b   Kilmarx, P H ^a,c   Wells, C D ^a   Samandari, Taraz ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Department of HIV AIDS Prevention and Care   (Botswana)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV AIDS; Isoniazid; Preventive therapy; Screening; Tuberculosis

Indexed keywords

ISONIAZID;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; EVALUATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PREVALENCE; PRIORITY JOURNAL; SCREENING; SYMPTOM; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; BOTSWANA; CD4 LYMPHOCYTE COUNT; CLINICAL TRIALS AS TOPIC; FEMALE; HIV INFECTIONS; HUMANS; ISONIAZID; MALE; MASS CHEST X-RAY; MASS SCREENING; PILOT PROJECTS; PREVALENCE; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS;

EID: 76149106513     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Corbett E L, Watt C J, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021.
2. Mwinga A, Hosp M, Godfrey-Faussett P, et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS 1998; 12: 2447-2457.
3. Whalen C C, Johnson J L, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 801-808.
4. Anonymous. Tuberculosis preventive therapy in HIV-infected individuals. A joint statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis and Lung Disease. Wkly Epidemiol Record 1993; 68: 361-364.
5. Botswana Ministry of Health. Evaluation of the tuberculosis isoniazid preventive therapy pilot programme for people living with HIV/AIDS. Gaborone, Botswana: Botswana Ministry of Health, 2001.
6. Mosimaneotsile B, Talbot E A, Moeti T L, et al. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet 2003; 362: 1551-1552.
7. Hudson C P, Wood R, Maartens G. Diagnosing HIV-associated tuberculosis: reducing costs and diagnostic delay. Int J Tuberc Lung Dis 2000; 4: 240-245.
8. Bruchfeld J, Aderaye G, Palme I B, et al. Evaluation of out-patients with suspected pulmonary tuberculosis in a high HIV prevalence setting in Ethiopia: clinical, diagnostic and epidemiological characteristics. Scand J Infect Dis 2002; 34: 331-337.
9. Mohammed A, Ehrlich R, Wood R, et al. Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy. Int J Tuberc Lung Dis 2004; 8: 792-795.
10. Mtei L, Matee M, Herfort O, et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 2005; 40: 1500-1507.
11. Kimerling M E, Schuchter J, Chanthol E, et al. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis 2002; 6: 988-994.
12. Were W, Moore D, Ekwaru P, et al. A simple screening tool for active tuberculosis in HIV-infected adults receiving antiretroviral treatment in Uganda. Int J Tuberc Lung Dis 2009; 13: 47-53.
13. den Boon S, White N W, van Lill S W, et al. An evaluation of symptom and chest radiographic screening in tuberculosis prevalence surveys. Int J Tuberc Lung Dis 2006; 10: 876-882.
14. Corbett E L, Bandason T, Cheung Y B, et al. Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med 2007; 4: e22.
15. Wood R, Middelkoop K, Myer L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 2007; 175: 87-93.
16. Day J H, Charalambous S, Fielding K L, et al. Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int J Tuberc Lung Dis 2006; 10: 523-529.
17. Cohn D L. Subclinical tuberculosis in HIV-infected patients: another challenge for the diagnosis of tuberculosis in high-burden countries? Clin Infect Dis 2005; 40: 1508-1510.
18. Selkon J B, Devadatta S, Kulkarni K G, et al. The emergence of isoniazid-resistant cultures in patients with pulmonary tuberculosis during treatment with isoniazid alone or isoniazid plus PAS. Bull World Health Organ 1964; 31: 273-294.
19. Espinal M A, Kim S J, Suarez P G, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000; 283: 2537-2545.
20. Nolan C M, Goldberg S V. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Int J Tuberc Lung Dis 2002; 6: 952-958.
21. Chintu C, Mwaba P. Is there a role for chest radiography in identification of asymptomatic tuberculosis in HIV-infected people? Lancet 2003; 362: 1516.
22. Mugisha B, Bock N, Mermin J, et al. Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda. Int J Tuberc Lung Dis 2006; 10: 761-767.
23. Smart T. Isoniazid preventive therapy for TB in people with HIV: barriers to national implementation. London, UK: AIDS-MAP. http://www.aidsmap.com/ cms1255961.asp Accessed February 2009.